|
SPAG5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6442399999983E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.20679999999307E-05 |
| Normal-vs-Stage2 |
2.86849999997507E-06 |
| Normal-vs-Stage3 |
6.20719999999686E-05 |
| Normal-vs-Stage4 |
3.756900E-04 |
| Stage1-vs-Stage2 |
2.643400E-01 |
| Stage1-vs-Stage3 |
6.891000E-01 |
| Stage1-vs-Stage4 |
4.865400E-01 |
| Stage2-vs-Stage3 |
2.141400E-01 |
| Stage2-vs-Stage4 |
1.421380E-01 |
| Stage3-vs-Stage4 |
7.361200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81005999999595E-05 |
| Normal-vs-AfricanAmerican |
4.73010000001661E-06 |
| Normal-vs-Asian |
5.93500000000136E-05 |
| Caucasian-vs-AfricanAmerican |
5.823200E-01 |
| Caucasian-vs-Asian |
9.781200E-01 |
| AfricanAmerican-vs-Asian |
8.639200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.93679999999286E-06 |
| Normal-vs-Female |
8.10950000000865E-05 |
| Male-vs-Female |
1.410030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.54902999999207E-05 |
| Normal-vs-Extreme_Weight |
1.21600000002609E-06 |
| Normal-vs-Obese |
4.64909999997598E-06 |
| Normal-vs-Extreme_Obese |
2.913200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.238400E-01 |
| Normal_Weight-vs-Obese |
9.318000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.832220E-01 |
| Extreme_Weight-vs-Obese |
1.927010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.278420E-01 |
| Obese-vs-Extreme_Obese |
1.768390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.414200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.76080999999551E-05 |
| Normal-vs-Age(61-80Yrs) |
1.56061999999624E-05 |
| Normal-vs-Age(81-100Yrs) |
7.04149999974923E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.216400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.434200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.043250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.267000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.449810E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.009600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.94679999998559E-06 |
| Normal-VS-Type2 PRCC |
1.583340E-04 |
| Normal-VS-KIRP CIMP |
8.13889999999873E-05 |
| Normal-VS-Unclassified PRCC |
1.93449999996709E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.641710E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.516000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.242400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.743200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.935890E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.385420E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.99110000000436E-05 |
| Normal-vs-N1 |
6.937500E-03 |
| Normal-vs-N2 |
1.182020E-03 |
| N0-vs-N1 |
9.250300E-02 |
| N0-vs-N2 |
9.351800E-01 |
| N1-vs-N2 |
4.387000E-01 |
|
|
